These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24382833)

  • 1. Prerecovery liver biopsy in the brain-dead donor: a case-control study of logistics, safety, precision, and utility.
    Oliver JB; Peters S; Bongu A; Beidas AK; Dikdan G; Brown L; Koneru B
    Liver Transpl; 2014 Feb; 20(2):237-44. PubMed ID: 24382833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsy in assessment of extended criteria donors.
    Oliver JB; Machineni P; Bongu A; Patel T; Nespral J; Kadric C; Goldstein MJ; Lerner H; Gee D; Hillbom R; Brown L; Washburn K; Koneru B
    Liver Transpl; 2018 Feb; 24(2):182-191. PubMed ID: 28941082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Full-Time Donor Management Protocol on Donors' Liver Biopsy Findings: Progress to Date.
    Mojtabaee M; Shamsaeefar A; Gholami S; Mohsenzadeh M; Sadegh Beigee F
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):269-272. PubMed ID: 28260484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
    Spitzer AL; Lao OB; Dick AA; Bakthavatsalam R; Halldorson JB; Yeh MM; Upton MP; Reyes JD; Perkins JD
    Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.
    Mancia C; Loustaud-Ratti V; Carrier P; Naudet F; Bellissant E; Labrousse F; Pichon N
    Transplantation; 2015 Aug; 99(8):1619-24. PubMed ID: 25719261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.
    Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A
    Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.
    Yersiz H; Lee C; Kaldas FM; Hong JC; Rana A; Schnickel GT; Wertheim JA; Zarrinpar A; Agopian VG; Gornbein J; Naini BV; Lassman CR; Busuttil RW; Petrowsky H
    Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.
    Oliver JB; Marcus AF; Paster M; Nespral J; Bongu A; Dikdan G; Brown L; Neidlinger N; Koneru B
    Transplantation; 2017 Apr; 101(4):821-825. PubMed ID: 28072757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal number of donor biopsy sites to evaluate liver histology for transplantation.
    Frankel WL; Tranovich JG; Salter L; Bumgardner G; Baker P
    Liver Transpl; 2002 Nov; 8(11):1044-50. PubMed ID: 12424718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Organ Retrieval Imaging System: results of the pilot study.
    Reddy MS; Bhati C; Neil D; Mirza DF; Manas DM
    Transpl Int; 2008 Nov; 21(11):1036-44. PubMed ID: 18764835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding postmortem donor pool using steatotic liver grafts: a new look.
    Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
    Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor age and outcome of liver transplantation.
    Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
    Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
    Nayak NC; Vasdev N; Saigal S; Soin AS
    Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
    Kosola S; Lampela H; Jalanko H; Mäkisalo H; Lohi J; Arola J; Pakarinen MP
    Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to intraoperative consultation for donor liver biopsies.
    Melin C; Miick R; Young NA; Ortiz J; Balasubramanian M
    Arch Pathol Lab Med; 2013 Feb; 137(2):270-4. PubMed ID: 23368870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience.
    Kaczmarek B; Manas MD; Jaques BC; Talbot D
    Transplant Proc; 2007 Nov; 39(9):2793-5. PubMed ID: 18021989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.